Trials / Completed
CompletedNCT00590525
Inflammation as a Predictor in Cardioversion of Atrial Fibrillation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- Creighton University · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The laboratory test, C-Reactive Protein (CRP), has become well established as a marker of inflammation. Recently a high CRP level (indicating an increase in inflammation) was identified as a risk factor for atrial fibrillation. We are conducting this study with patients such as yourself with atrial fibrillation who are planning to undergo cardioversion to determine what sort of relationship exists between CRP levels and atrial fibrillation. We will then look at success rates of converting atrial fibrillation to normal sinus rhythm, compared to patients' CRP levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Cardioversion | Baseline hsCRP will be drawn the morning of, prior to, cardioversion. An EKG to document the patient's rhythm will be obtained at the one-month mark |
Timeline
- Start date
- 2004-10-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2008-01-10
- Last updated
- 2009-12-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00590525. Inclusion in this directory is not an endorsement.